Osteoporosis Newswire (Page 2)

Comprehensive Real-Time News Feed for Osteoporosis. (Page 2)

Results 21 - 40 of 509 in Osteoporosis

  1. Eli Lilly buys rights to osteoporosis skin patchRead the original story w/Photo

    Tuesday Dec 2 | The Indianapolis Star

    Eli Lilly and Co. has bought the rights to develop an osteoporosis medicine developed by Zosano Pharma Corp. that delivers a hormone through a skin patch to treat the bone-thinning disease.

    Comment?

  2. Eli Lilly to License Zosano Osteoporosis TreatmentRead the original story w/Photo

    Tuesday Dec 2 | Wall Street Journal

    Eli Lilly & Co. said it entered an exclusive agreement to develop privately held biopharmaceutical firm Zosano Pharm Corp.'s experimental microneedle patch system to treat severe osteoporosis in a deal potentially valued at as much as $440 million.

    Comment?

  3. Bone Health To Be A Major Wellness Trend in 2015Read the original story

    Tuesday Dec 2 | Newswise

    City of Industry, CA - December 2, 2015 - If you think bone health is not sexy dinner conversation, just wait until you break one. According to the National Osteoporosis Foundation, 15% of all women will break a bone in their lifetime.

    Comment?

  4. Radiofrequency Ablation Devices Market 2020 - Industry Survey,...Read the original story

    Tuesday Dec 2 | PR-inside.com

    Industry Insights As per the analyses of International Osteoporosis Foundation, osteoporosis causes 8.9 million fractures annually, resulting in a fracture every 3 seconds. Rising prevalence of target disorders such as osteoporosis pain, benign prostatic obstruction is a high impact rendering driver for the growth of radiofrequency ablation devices market.

    Comment?

  5. Studies probe why osteoporosis drugs may prevent cancerRead the original story

    Monday Dec 1 | HawaiiNews

    International researchers said Monday they have made steps toward understanding why the most commonly used drugs for osteoporosis worldwide, known as bisphosphonates, may also prevent some kinds of lung, breast and colon cancers. If confirmed in clinical trials, the findings could accelerate the use of drugs like alendronic acid , zoledronic acid and ibandronic acid to prevent tumors or treat them in their early stages, according to two studies in the Proceedings of the National Academy of Sciences.

    Comment?

  6. Chemotherapy side effects after treatment is doneRead the original story

    Saturday Nov 29 | San Diego NewsCape

    ... changes in your heart's function. If you're a woman undergoing chemotherapy, you're at an increased risk of osteoporosis. Cancer drugs can disrupt your hormone system, leading to reduced levels of estrogen, which has a protective effect on bone. You ...

    Comment?

  7. To Your Good Health: Listen up! It takes time to get used to hearing aidsRead the original story w/Photo

    Friday Nov 28 | TwinCities

    ... a primary care doctor or a psychiatrist, is essential for treatment. Q: I am a 66-year-old woman with moderate osteoporosis, according to a bone density test done two months ago. My T-score in the lumbar spine was -0.6; in the left hip -0.3; and in ...

    Comment?

  8. A practical toolkit to implement coordinator-based fracture liaison servicesRead the original story w/Photo

    Thursday Nov 27 | Medical News

    ... 80% of individuals who experience a fragility fracture are never offered screening and/or treatment for osteoporosis even though they are twice as likely to suffer a fracture in the future. Left undiagnosed and unprotected, these patients often go ...

    Comment?

  9. China osteoporosis drugs market: $1.6 billion industry in 2012Read the original story w/Photo

    Wednesday Nov 26 | PR-inside.com

    The report also discusses in detail the osteoporotic diagnostic services and equipments in China with DXA and QUS being the broad categories. Finally the report also gives a brief snapshot of the Hong Kong and Taiwan Osteoporosis markets.

    Comment?

  10. Scientists link gene to tamoxifen-resistant breast cancersRead the original story w/Photo

    Tuesday Nov 25 | PhysOrg Weblog

    ... to estrogen-blocking drugs such as tamoxifen. Results of a new study, ... A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted ...

    Comment?

  11. New toolkit to aid implementation of fracture liaison servicesRead the original story w/Photo

    Monday Nov 24 | EurekAlert!

    ... 80% of individuals who experience a fragility fracture are never offered screening and/or treatment for osteoporosis even though they are twice as likely to suffer a fracture in the future. Left undiagnosed and unprotected, these patients often go ...

    Comment?

  12. Endocrine Society issues Clinical Practice Guideline on rare bone conditionRead the original story w/Photo

    Sunday Nov 23 | Medical News

    ... who are younger than age 40. "We've long known that bisphosphonates - a class of drugs often used to treat osteoporosis and other bone conditions - work well for treating Paget's disease," said Frederick R. Singer, MD, of the John Wayne Cancer ...

    Comment?

  13. Tetraphase said to explore sale, Bloomberg reportsRead the original story

    Nov 10, 2014 | Theflyonthewall.com

    Teva patent victory over Warner Chilcott, Roche affirmed The U.S. Court of Appeals for the Federal Circuit ruled that a district court was correct to grant summary judgment to Teva in a patent dispute with Warner Chilcott and Roche over patents related to osteoporosis drug risedronate. CVS Express Scripts implementing drug price controls, says Cleveland Research Cleveland Research believes that CVS and Express scripts are implementing rebates and price controls on drug.

    Comment?

  14. Denosumab reverses bone loss, lowers wrist fracture rates in women with osteoporosisRead the original story w/Photo

    Nov 16, 2014 | Science Daily

    Denosumab reversed cortical bone loss and increased bone mineral density, lowering wrist fracture rates in women with osteoporosis, according to new research. Osteoporosis is a common condition where bones become weak, affecting both men and women, mainly as they grow older.

    Comment?

  15. Estrogen's role in regulating common health disease risks identifiedRead the original story w/Photo

    Nov 13, 2014 | Science Daily

    ... body could lead to aspects of metabolic syndrome, a combination of conditions that can - Estrogen treatment for osteoporosis has often been associated with serious side effects. Researchers in Sweden have now, in mice, found a way of utilizing the ...

    Comment?

  16. Singapore Press-Amgen opens S$200 mln plant in Singapore-Straits TimesRead the original story

    Thursday Nov 20 | Reuters

    American pharmaceutical giant Amgen officially opened a S$200 million biomanufacturing facility in Tuas on Thursday, the Straits Times reported. The 120,000 sq ft plant, the company's first manufacturing site in Asia, will produce a drug substance used to treat osteoporosis and bone-related disorders in cancer patients.

    Comment?

  17. New FRAX version 3.9 extends fracture risk assessment tool to four more countriesRead the original story w/Photo

    Thursday Nov 20 | PhysOrg Weblog

    The fracture risk assessment calculator FRAX is a widely utilized clinical tool which calculates an individual's 10-year probability of osteoporotic fracture. Developed by the Centre for Metabolic Bone Diseases, University of Sheffield, UK and supported by the International Osteoporosis Foundation, this freely accessible online tool assists primary health-care providers to better target patients most likely to benefit from osteoporosis treatment.

    Comment?

  18. Senate Health, Education, Labor & Pensions Committee to hold a hearingRead the original story

    Nov 6, 2014 | Theflyonthewall.com

    Senate Health, Education, Labor & Pensions Committee to hold a hearing The Subcommittee on Primary Health and Aging holds a hearing entitled, "Why Are Some Generic Drugs Skyrocketing In Price?" with President & CEO Vigodman of Teva Pharmaceutical and President & CEO Bedrosian of Lannett Company on November 20 at 1 pm. Webcast Link Teva patent victory over Warner Chilcott, Roche affirmed The U.S. Court of Appeals for the Federal Circuit ruled that a district court was correct to grant summary judgment to Teva in a patent dispute with Warner Chilcott and Roche over patents related to osteoporosis drug risedronate.

    Comment?

  19. Intellipharmaceutics notes launch of 5mg strength Focalin XR by TevaRead the original story

    Nov 7, 2014 | Theflyonthewall.com

    Teva patent victory over Warner Chilcott, Roche affirmed The U.S. Court of Appeals for the Federal Circuit ruled that a district court was correct to grant summary judgment to Teva in a patent dispute with Warner Chilcott and Roche over patents related to osteoporosis drug risedronate. Teva calls active on renewed takeover chatter Teva November 57 and 58 calls are active on total call volume of 21K contracts following renewed takeover chatter.

    Comment?

  20. Experts suggest single dose IV medication as first-choice treatment for Paget's diseaseRead the original story w/Photo

    Nov 19, 2014 | PhysOrg Weblog

    ... who are younger than age 40. "We've long known that bisphosphonates - a class of drugs often used to treat osteoporosis and other bone conditions - work well for treating Paget's disease," said Frederick R. Singer, MD, of the John Wayne Cancer ...

    Comment?